Abstract |
The α- isozyme of diacylglycerol kinase (DGK) enhances cancer cell proliferation and, conversely, it promotes the nonresponsive immune state known as T-cell anergy. Moreover, a DGKα-selective inhibitor, CU-3, induced cell death in cancer-derived cells and simultaneously enhanced T-cell interleukin-2 production. In addition to DGKα, DGKζ is also known to induce T-cell anergy. In the present study, we examined whether combined inhibition/silencing of DGKα and DGKζ synergistically enhanced T-cell activity. Combined treatment with CU-3 or DGKα- small interfering RNA ( siRNA) and DGKζ- siRNA more potently enhanced T-cell receptor-crosslink-dependent interleukin-2 production in Jurkat T cells than treatment with either alone. Intriguingly, in addition to activating T cells, dual inhibition/silencing of DGKα and DGKζ synergistically reduced viability and increased caspase 3/7 activity in AKI melanoma cells. Taken together, these results indicate that combined inhibition/silencing of DGKα and DGKζ simultaneously and synergistically enhances interleukin-2 production in T cells and induces cell death in melanoma. Therefore, dual inhibition/silencing of these DGK isozymes represents an ideal therapy that potently attenuates cancer cell proliferation and simultaneously enhances immune responses that impact anticancer immunity.
|
Authors | Saki Takao, Rino Akiyama, Fumio Sakane |
Journal | Journal of cellular biochemistry
(J Cell Biochem)
Vol. 122
Issue 5
Pg. 494-506
(05 2021)
ISSN: 1097-4644 [Electronic] United States |
PMID | 33399248
(Publication Type: Journal Article)
|
Copyright | © 2020 Wiley Periodicals LLC. |
Chemical References |
- Interleukin-2
- Diacylglycerol Kinase
|
Topics |
- Apoptosis
(physiology)
- Blotting, Western
- Cell Death
(physiology)
- Cell Line
- Cell Survival
(physiology)
- Diacylglycerol Kinase
(genetics, metabolism)
- Humans
- Interleukin-2
(metabolism)
- Jurkat Cells
(metabolism)
- RNA Interference
- T-Lymphocytes
(metabolism)
|